UroGen Pharma
URGN
#5548
Rank
S$1.74 B
Marketcap
S$35.67
Share price
-12.86%
Change (1 day)
8.08%
Change (1 year)

EPS for UroGen Pharma (URGN)

EPS in 2026 (TTM): S-$1.70

According to UroGen Pharma's latest financial reports the company's current EPS (TTM) is S-$1.70. In 2025 the company made an earnings per share (EPS) of S-$4.13 a decrease over its 2024 EPS that were of S-$3.87.

EPS history for UroGen Pharma from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.70-58.88%
2025S-$4.136.67%
2024S-$3.87
2022S-$6.17-3.63%
2021S-$6.40-16.22%
2020S-$7.64
2018S-$6.14160.58%
2017S-$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74 2.27%๐Ÿ‡บ๐Ÿ‡ธ USA